p38 MAPK Antagonist
-
Glucagon receptor antagonist-8
0 ImagesCat. No.: HY-177156CAS No.: 208182-31-4Glucagon receptor antagonist-8 (Compound 1) is a human glucagon receptor and p38 mitogen-activated protein (MAP) kinase antagonist, with IC50s of 0.27 μM and 0.16 μM, respectively.
-
ST-162
0 ImagesCat. No.: HY-124615CAS No.: 1883817-83-1ST-162 is a MAPK/PI3K dual antagonist. ST-162 exhibits antitumor activity and can increase the efficacy of immune checkpoint blockers. ST-162 can be used for the research of cancer, such as melanoma.
